Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab

M Walraven; Marjolein Homs; Astrid van der Veldt; H Dekker; J Koldenhof; R Honeywell; A Barendrecht; SAE Sebastian; N Parr; AC Koekman; EE Voest; M Roest; SJA Korporaal; HMW Verheul

doi:10.1007/s10456-018-9598-5

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab

M Walraven, Marjolein Homs, Astrid van der Veldt, H Dekker, J Koldenhof, R Honeywell, A Barendrecht, SAE Sebastian, N Parr, AC Koekman, EE Voest, M Roest, SJA Korporaal, HMW Verheul

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Scopus)

2 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	325-334
Number of pages	10
Journal	Angiogenesis
Volume	21
Issue number	2
DOIs	https://doi.org/10.1007/s10456-018-9598-5
Publication status	Published - 2018

Access to Document

10.1007/s10456-018-9598-5

RePub-111214-OA.pdfFinal published version, 1.14 MB

http://hdl.handle.net/1765/111214

Cite this

Walraven, M., Homs, M., van der Veldt, A., Dekker, H., Koldenhof, J., Honeywell, R., Barendrecht, A., Sebastian, SAE., Parr, N., Koekman, AC., Voest, EE., Roest, M., Korporaal, SJA., & Verheul, HMW. (2018). Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab. Angiogenesis, 21(2), 325-334. https://doi.org/10.1007/s10456-018-9598-5

@article{9b47076c62be472c9e77a22efb60ca29,

title = "Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab",

author = "M Walraven and Marjolein Homs and {van der Veldt}, Astrid and H Dekker and J Koldenhof and R Honeywell and A Barendrecht and SAE Sebastian and N Parr and AC Koekman and EE Voest and M Roest and SJA Korporaal and HMW Verheul",

year = "2018",

doi = "10.1007/s10456-018-9598-5",

language = "Undefined/Unknown",

volume = "21",

pages = "325--334",

journal = "Angiogenesis",

issn = "0969-6970",

publisher = "Springer Netherlands",

number = "2",

}

Walraven, M, Homs, M , van der Veldt, A, Dekker, H, Koldenhof, J, Honeywell, R, Barendrecht, A, Sebastian, SAE, Parr, N, Koekman, AC, Voest, EE, Roest, M, Korporaal, SJA & Verheul, HMW 2018, 'Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab', Angiogenesis, vol. 21, no. 2, pp. 325-334. https://doi.org/10.1007/s10456-018-9598-5

TY - JOUR

T1 - Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab

AU - Walraven, M

AU - Homs, Marjolein

AU - van der Veldt, Astrid

AU - Dekker, H

AU - Koldenhof, J

AU - Honeywell, R

AU - Barendrecht, A

AU - Sebastian, SAE

AU - Parr, N

AU - Koekman, AC

AU - Voest, EE

AU - Roest, M

AU - Korporaal, SJA

AU - Verheul, HMW

PY - 2018

Y1 - 2018

U2 - 10.1007/s10456-018-9598-5

DO - 10.1007/s10456-018-9598-5

M3 - Article

VL - 21

SP - 325

EP - 334

JO - Angiogenesis

JF - Angiogenesis

SN - 0969-6970

IS - 2

ER -